The results showed that compared with the control group, there were only six genes (CD2, CD8A, GNLY, IFI44, NKG7, and OAS2) with statistically significant differences in expression in the UC and NASH validated datasets (Fig. 5a, b). This evidence concerns the gene CD2 and metabolic dysfunction-associated steatohepatitis.